RAD December 2022 Abstracts and Posters
All accepted abstracts have been published in The British Journal of Dermatology, Volume 188, Issue Supplement 2, February 2023. You may access the publication at: https://academic.oup.com/bjd/issue/188/Supplement_2#337 - Dupilumab Treatment Is Not Associated With an Increased Overall Risk of Infections in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis
Elaine C. Siegfried, Michael J. Cork, Peter D. Arkwright, Andreas Wollenberg, Lawrence F. Eichenfield, Michele Ramien, Faisal A. Khokhar, Zhen Chen, Annie Zhang, Sonya L. Cyr
#338 - Laboratory Safety From a 16-week Phase 3 Study of Dupilumab in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis
Amy S. Paller, Andreas Wollenberg, Elaine C. Siegfried, Mercedes E. Gonzalez, Benjamin Lockshin, Faisal A. Khokhar, Zhen Chen, Tayler Gonzalez, Randy Prescilla
#339 - Dupilumab 16-Week Efficacy and Safety Is Robust and Consistent in Adults Over 60 Years of Age With Moderate-to-Severe Atopic Dermatitis
Jonathan I. Silverberg, Charles W. Lynde, Katrina Abuabara, Cataldo Patruno, Anna De Benedetto, Faisal A. Khokhar, Ainara Rodriguez Marco, Noah A. Levit
#340 - Dupilumab Treatment of Children with Moderate-to-Severe Atopic Dermatitis Increases Bone Alkaline Phosphatase, a Marker of Bone Mineralization
Alan D. Irvine, Amy S. Paller, Sara Hamon, Julie Horowitz, Annamaria Farrell, Sarah Hatsell, Ainara Rodríguez Marco, Ashish Bansal, Zhen Chen4, Sonya L. Cyr
#341 - Dupilumab Improves Itch and Skin Lesions in Adults with Prurigo Nodularis Regardless of Prior Use of Immunosuppressants or Phototherapy: Post Hoc Results from PRIME and PRIME2 Clinical Trials
Shawn G. Kwatra, Gil Yosipovitch, Sonja Ständer, Brian S. Kim, Jérôme Msihid, Ashish Bansal, Renata Martinčová, Simmi Wiggins, Noah A. Levit, Ryan B. Thomas, Donia Bahloul
#342 - A Case Series of Live Attenuated Vaccine Administration in Dupilumab-Treated Children with Atopic Dermatitis
Elaine C. Siegfried, Lara Wine Lee, Jonathan M. Spergel, Sumeet Uppal, Anna Coleman, Brad Shumel, Randy Prescilla, Ashish Bansal, Sonya L. Cyr
#343 - Dupilumab Efficacy on Itch and Skin Lesions in Adult Patients with Prurigo Nodularis May be Observed Concurrently or Independently Over 24 Weeks: Results from Two Phase 3 Trials
Shawn G. Kwatra, Gil Yosipovitch, Sonja Ständer, Pedro Mendes-Bastos, Tsen-Fang Tsai, Saeko Nakajima, Amy Praestgaard, Ashish Bansal, Renata Martinčová, Noah A. Levit8, Simmi Wiggins
#344 - Dupilumab Significantly Improves Itch and Skin Lesions in Patients with Prurigo Nodularis: Pooled Results from Two Phase 3 Trials (LIBERTY-PN PRIME and PRIME2)
Gil Yosipovitch, Shawn G. Kwatra, Nicholas Mollanazar, Sonja Ständer, Takahiro Satoh, Elizabeth Laws, Leda P. Mannent, Eric Mortensen, Jennifer Maloney, Genming Shi, Ashish Bansal, Renata Martinčová
#345 - Treatment With Amlitelimab ‒ A Novel Non-Depleting, Non-Cytotoxic Anti-OX40Ligand Monoclonal Antibody ‒ Reduces IL-22 Serum Levels in a Phase 2a Randomized, Placebo-Controlled Trial in Patients With Moderate-to-Severe Atopic Dermatitis
Stephan Weidinger, Michael Cork, Adam Reich, Thomas Bieber, Sally Gilbert, Nuala Brennan, Rosamund Wilson, Davide Lucchesi, Natalie Rynkiewicz, Marisa Stebegg, Ben Porter-Brown
#347 - The Real-World Burden of Atopic Dermatitis: MEASURE-AD Multicountry Study Results From Brazil, Mexico, and Argentina
Roberta Fachini Jardim Criado, Tatiane Rodrigues, Lucila de Campos, Tania Cestari, Jorge Maspero, Paula Carolina Luna, María Valeria Angles, Martti Antila